Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions

Journal of Dermatological Science

Volumn 19, Issue 1, 1999, Pages 53-67

  Wrone Smith, Tamara ^a   Bergstrom, Jane ^a   Quevedo, Maria Eugenia ^a   Reddy, Vijaya ^a   Gutierrez Steil, Christina ^a   Nickoloff, Brian J ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Bcl x; Differentiation; Keratinocyte; Proliferation; Squamous cell carcinoma

Indexed keywords

DNA; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL CYCLE PROTEINS; CELL NUCLEUS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032890441     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00052-8     Document Type: Article

References (46)

1. Yuspa S.H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res. 54:1994;1178-1189.
2. Ellis R.E., Yuan J., Horvitz H. Mechanisms and functions of cell death. Ann. Rev. Cell. Biol. 7:1991;663-692.
3. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
4. Haake A.R., Polakowska R.R. Cell death by apoptosis in epidermal biology. J. Invest. Dermatol. 101:1993;107-112.
5. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
6. Hockenberry D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
7. Boise L.H., Gonzalez-Garcia M., Postema C.E. et al. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
8. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
9. L and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:1995;821-828.
10. Hockenbery D.M., Zutter M., Hickey W., Nahm M., Korsmeyer S.J. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA. 88:1991;6961-6965.
11. Krajewski S., Krajewska M., Shabaik A., Wang H.-G., Irie S., Fong L., Reed J.C. Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res. 54:1994;5501-5507.
12. Wrone-Smith T., Johnson T., Nelson B., Boise L.H., Thompson C.B., Nunez G., Nickoloff B.J. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am. J. Pathol. 146:1995;1079-1088.
13. Nakagawa K., Yamamura K., Maeda S., Ichihashi M. Bcl-2 expression in epidermal keratinocyte diseases. Cancer. 74:1994;1720-1724.
14. Ziegler A., Jonason A.S., Leffell D.J. et al. Sunburn and p53 in the onset of skin cancer. Nature. 372:1994;773-776.
15. Nomura T., Nakajima H., Hongyo T. et al. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer Res. 57:1997;2081-2084.
16. cip1/waf1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science. 280:1998;1069-1072.
17. waf1 in human cutaneous squamous cell carcinoma. Am. J. Pathol. 149:1996;1139-1146.
18. ink4a is associated with, but not sufficient for, induction of squamous differentiation. J. Cell. Sci. 111:1998;1185-1196.
19. Gerdes J., Li L., Schluter C. et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138:1991;867-873.
20. Nickoloff B.J., Karabin G.D., Barker J.N.W.N. et al. Cellular localization of interleukin-8 and its inducer tumor necrosis factor-α in psoriasis. Am. J. Pathol. 138:1991;129-140.
21. Gottschalk A.R., Boise L.H., Thompson C.B., Quintans J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA. 91:1994;7350-7354.
22. Gavrieli Y., Sherman Y., Ben Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
23. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H.G., Reed J.C. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145:1994;1323-1336.
24. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas: A mechanism for evading the local T cell immune response. J Immunol 1995:2240-2247.
25. Gutierrez-Steil C., Wrone-Smith T., Sun X., Krueger J.G., Coven T., Nickoloff B.J. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Invest. 101:1998;33-39.
26. Rodriguez-Villanueva J., Colome M.I., Brisbay S., McDonnell T.J. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers. Pathol. Res. Pract. 191:1995;391-398.
27. Smoller B.R., Van De Rijn M., LeBrun D., Warnke R. Bcl-2 expression reliably distinguished trichoepitheliomas from basal cell carcinomas. Br. J. Cancer. 131:1994;28-31.
28. Sleater J.P., Beers B.B., Stephens C.A., Hendricks J.B. Keratoacanthoma: A deficient squamous cell carcinoma? Study of bcl-2 expression. J. Cutan. Pathol. 21:1994;514-519.
29. Morales-Ducret C.R.J., van de Rijn M., LeBrun D.P., Smoller B.R. Bcl-2 expression in primary malignancies of the skin. Arch. Dermatol. 131:1995;909-912.
30. Polakowska R.R., Piacentini M., Bartlett R., Goldsmith L.A., Haake A.R. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Del. Dynam. 199:1994;176-188.
31. Mansbridge J.N., Knapp A.M. Changes in keratinocyte maturation during wound healing. J. Invest. Dermatol. 89:1987;253-263.
32. L. Cell. 3:1995;87-98.
33. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
34. Jaattela M., Benedict M., Tewari M., Shayman J.A., Dixit V.M. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene. 10:1995;2297-2305.
35. Teixeira C., Reed J., Pratt C. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:1995;3902-39071.
36. Raffo A.J., Perlman H., Chen M.-W., Day M.L., Streitman J.S., Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55:1995;4438-4445.
37. Wrone-Smith T., Mitra R.S., Thompson C.B., Jasty R., Castle V.P., Nickoloff B.J. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared to normal skin. Am. J. Pathol. 151:1997;1321-1329.
38. Pena J.C., Fuchs E., Thompson C.B. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth. Differ. 8:1997;619-629.
39. L transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res. 58:1998;2111-2116.
40. Reeve J.G., Xiong J., Morgan J., Bleehen N.M. Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. Br. J. Cancer. 73:1996;1193-1200.
41. Krajewska M., Krajewski S., Epstein J.I. et al. Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-2 expression in prostate cancers. Am. J. Pathol. 148:1996;1567-1576.
42. Oltavi Z.N., Korsmeyer S.J. Checkpoints of dueling dimers foil death wishes. Cell. 179:1994;189-192.
43. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
44. Dotto P. The keratinocyte growth-differentiation switch. Frontiers Biosci. 3:1998;502-512.
45. Olivetti G, Abbi R, Quaini F et al. Apoptosis in the failing human heart. New Engl. J. Med. 366:1997;1131-1141.
46. Pandey S., Wang E. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and Rb phosphorylation, resembling events of early cell-cycle traverse. J. Cell Biochem. 58:1995;135-150.